Trending/aducanumab
Drugmaker presents data on new Alzheimer’s drug
The company that makes aducanumab for Alzheimer's disease says that the drug slows mental decline. Biogen Inc. revealed its new analyses of data from its phase 3…
October 22, 2019
Special Topics
Sign up
Social Media Network
A network for digital healthcare communicators
Mayo Clinic Connect
An online patient support community